Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 25 Oct 2019 – 20 Aug 2026, limited by ITI ELSS Tax Saver Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ITI ELSS Tax Saver Fund | Nifty 500 |
|---|---|---|
| 25 Oct 2019 | ₹100.00 | ₹100.00 |
| 20 May 2020 | ₹79.61 | ₹78.75 |
| 13 Dec 2020 | ₹117.28 | ₹118.45 |
| 09 Jul 2021 | ₹147.61 | ₹143.44 |
| 01 Feb 2022 | ₹145.79 | ₹160.28 |
| 28 Aug 2022 | ₹146.08 | ₹160.61 |
| 24 Mar 2023 | ₹144.77 | ₹151.40 |
| 17 Oct 2023 | ₹183.18 | ₹185.21 |
| 12 May 2024 | ₹238.28 | ₹217.04 |
| 05 Dec 2024 | ₹275.63 | ₹246.82 |
| 01 Jul 2025 | ₹277.92 | ₹250.40 |
| 24 Jan 2026 | ₹253.78 | ₹240.76 |
| 20 Aug 2026 | ₹291.32 | ₹249.31 |
| Metric | ITI · Direct NAV ₹29.31 Very High risk ★★★★☆ | Category median ELSS · 51 funds |
|---|---|---|
| +8.43% | +3.05% | |
| +19.54% | +14.46% | |
| +15.20% | +13.60% | |
| — | +13.74% | |
| +16.97% | +14.97% | |
| +16.43% | — | |
| +20.57% | +16.84% | |
| +19.07% | +17.15% | |
| — | +15.41% | |
| Risk | ||
| 17.49% | 14.19% | |
| 0.74 | 0.52 | |
| 1.02 | 0.70 | |
| -38.49% | -35.94% | |
| Nifty 500 | — | |
| +5.51% | +1.57% | |
| 1.23 | 0.97 | |
| 137.2% | 102.3% | |
| 122.1% | 93.6% | |
| 0.90% | 1.06% | |
| ₹427.06Cr | ₹765.87Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 443% | 34% | |
| Alok Ranjan | — | |
| 25 Oct 2019 | — | |
| 71 | — | |
| 26.4% | — | |
| 2.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.